| Type : |
Journal |
| Web link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=284 |
|
| Research teams : |
Houston - M.D.Anderson Cancer Center |
| Authors : |
Zhang YP, Trissel LA, Fox JL. |
| Title : |
Naratriptan hydrochloride in extemporaneously compounded oral suspensions. |
| Reference : |
Int J Pharm Compound ; 4: 69-71. 2000 |
|
| Level of Evidence : |
|
| Physical stability : |
|
| Chemical stability : |
|
| Other methods : |
|
| Comments : |
|
List of drugs
 Naratriptan Hydrochloride
|
 |
 |
 |
 |
15 mg
Amerge® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
23°C |
 |
| 7 |
 |
|
|
|
|
|
15 mg
Amerge® |
| OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
23°C |
|
| 7 |
|
|
|
|
|
|
15 mg
Amerge® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
4°C |
|
| 90 |
|
|
|
|
|
|
15 mg
Amerge® |
| OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
4°C |
|
| 90 |
|
|
|
|
|
